Clinical Trials Logo

Altitude Hypoxia clinical trials

View clinical trials related to Altitude Hypoxia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05966714 Active, not recruiting - Clinical trials for Neonatal Encephalopathy

Neonatal Cerebral Oxygenation and Electrical Activity at Different Altitude Levels

Start date: June 30, 2023
Phase:
Study type: Observational

In this study, the objective is to compare neonatal cerebral oxygenation and electrical activity within 3 days after birth across different altitude areas using non-invasive methods, specifically near infrared spectroscopy (NIRS) and amplitude-integrated electroencephalography (aEEG), and establish reference value for each altitude level.

NCT ID: NCT05517044 Active, not recruiting - Clinical trials for Perfusion; Complications

The Pre-acclimatization Augmented Extreme Altitude Expedition

PRAGMAX
Start date: August 4, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of pre-acclimatization in a nitrogen tent at home, ventilated with a slightly increased nitrogen percentage, in preparation for an expedition at extreme altitude. Specifically, the current study aims to gather knowledge, whether pre-acclimatization, first, leads to improved capillary function during an expedition to extreme altitude, and second, affects incidence of altitude sickness and the likelihood of reaching the expedition destination without oxygen supplementation. The project will be carried out in two phases corresponding to two randomized controlled trials in healthy volunteers, who are participating in an expedition at extreme altitudes with or without pre-acclimatization.

NCT ID: NCT05500014 Active, not recruiting - Clinical trials for Iron Deficiency Anemia

Effect of Altitude on Iron Absorption in Iron Depleted Women

PotatoAlt
Start date: August 20, 2022
Phase: N/A
Study type: Interventional

One of the most common nutritional deficiencies worldwide is iron deficiency. Iron deficiency is considered the main cause of anaemia in developing countries, including those in South America. The most recent surveys report that the prevalence of anaemia is as high as, 40 and 25% in Peru. Populations living at higher altitudes may have higher iron requirements, as body iron is naturally increased in long-term high-altitude residents to compensate for the lower oxygen in the air at high altitudes. However, the effects of chronic exposure to high altitude on iron status, body iron compartments and dietary iron requirements are incompletely understood. The primary objective of the proposed research is to determine iron bioavailability of iron from biofortified potatoes at different altitudes in populations of Andean descent. Human trials will be undertaken with volunteers in the Huancavelica region of Peru (elevation: 3676 meters) as well as in Lima (elevation close to sea level). The aim is to assess the effect of altitude on the absorption from a promising iron biofortified potato cultivar. These trials require incorporation of iron stable isotopes into the meals of the bio fortified potato and the analysis of the isotopes in subsequent blood (red blood cells) samples. Stable iron istotopes are considered the golden standard to assess human iron absorption and can be safely used as tracer substances in humans. The objective of the study is to compare, in volunteer females of childbearing age, the bioavailability of iron from bio-fortified potatoes in two locations of different altitudes and quantify the effect of altitude on iron bioavailability from a potato meal consumed over 5 consecutive days.

NCT ID: NCT04913389 Active, not recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD

Start date: June 1, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this randomized, placebo-controlled double-blind trial is to evaluate efficacy of acetazolamide in preventing overt altitude-related adverse health effects (ARAHE) in lowlanders with chronic obstructive pulmonary disease (COPD) developing early signs of altitude-illness during altitude travel.

NCT ID: NCT03540914 Active, not recruiting - Altitude Hypoxia Clinical Trials

Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude.

Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

Randomized, placebo controlled trial evaluating efficacy of acetazolamide on right heart function at rest in lowlanders older than 40 years travelling from 760 m to 3'100 m.

NCT ID: NCT03539367 Active, not recruiting - Altitude Hypoxia Clinical Trials

Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude

Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

Randomized, placebo controlled trial evaluating the effect of acetazolamide on lung water content by ultrasound in lowlanders older than 40 years travelling from 760 m to 3'100 m.

NCT ID: NCT03537924 Active, not recruiting - Altitude Hypoxia Clinical Trials

Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude

Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

Randomized, placebo controlled trial evaluating efficacy of acetazolamide on right heart function during exercise in lowlanders older than 40 years travelling from 760 m to 3'100 m.